Proteome Sciences has established a comprehensive intellectual property portfolio covering markers in CNS disorders (Alzheimer’s, stroke, traumatic brain injury, TSE’s & pain), Oncology (lung, breast, esophageal, colorectal cancers & neuroblastoma) and organ transplant rejection (renal, cardiac).
All biomarker portfolios are available for licensing to companies wishing to develop targeted assays for research and/or clinical use. Further details on each biomarker portfolio can be obtainied by sending a request to info@proteomcis.com or by telephone to (+44 (0) 1932 865065)
A list of selected applications from tissue and body fluids is set out below:
